drugset / Trial / NCT01578473

Testosterone Pellets Plus Vitamin D and E Versus Vitamin D and E Alone for the Treatment of Peyronie's Disease

NCT01578473

Phase 1 Completed 75 enrolled Men's Health Boston
RandomizedParallel-groupOpen-labelTreatment

Summary

Two recent studies have identified low levels of serum testosterone in association with Peyronie's Disease (PD), with a significant correlation noted between severity of testosterone deficiency and severity of curvature. The study hypothesis is to determine whether treatment with testosterone may help men with PD and penile curvature.

Timeline

Start
2013-05-23
Primary completion
2013-07-07
Completion
2017-11-13

Drugs

EvaluationDrugModalityDoseRoute
Comparator Testosterone Small molecule 75 mg Subcutaneous
Comparator Ergocalciferol Small molecule 2000 iu Oral
Comparator Vitamin E Other / unclassified 200 iu Oral
Comparator Vitamin E Other / unclassified 400 iu Oral

Indications